(Q35538840)

8 August 2017

1 reference

title

M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy (English)

1 reference

https://api.crossref.org/works/10.1385/JMN:20:3:349

8 August 2017

M<sub>1</sub> Muscarinic Agonists Can Modulate Some of the Hallmarks in Alzheimer's Disease: Implications in Future Therapy (English)

1 reference

12 March 2024

0 references

Abraham Fisher

1

1 reference

8 August 2017

Zipora Pittel

2

1 reference

8 August 2017

Rachel Haring

3

1 reference

8 August 2017

Nira Bar-Ner

4

1 reference

8 August 2017

Michal Kliger-Spatz

5

1 reference

8 August 2017

Niva Natan

6

1 reference

8 August 2017

Inbal Egozi

7

1 reference

8 August 2017

Hagar Sonego

8

1 reference

8 August 2017

Itzhak Marcovitch

9

1 reference

8 August 2017

Rachel Brandeis

10

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14501019

12 March 2024

publication date

1 January 2003

1 reference

full work available at URL

8 August 2017

http://www.springerlink.com/index/pdf/10.1385/JMN:20:3:349

1 reference

https://api.crossref.org/works/10.1385/JMN:20:3:349

Journal of Molecular Neuroscience

12 March 2024

published in

1 reference

8 August 2017

volume

20

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

349-356

1 reference

Activation of protein kinase C inhibits cellular production of the amyloid beta-protein

8 August 2017

cites work

1 reference

12 December 2020

Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells

1 reference

12 December 2020

Muscarinic agonists reduce tau phosphorylation in non-neuronal cells via GSK-3beta inhibition and in neurons.

1 reference

12 December 2020

Reduction of cerebrospinal fluid amyloid beta after systemic administration of M1 muscarinic agonists

1 reference

12 December 2020

Site-specific dephosphorylation of tau of apolipoprotein E-deficient and control mice by M1 muscarinic agonist treatment

1 reference

12 December 2020

Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor

1 reference

12 December 2020

Muscarinic agonists for the treatment of Alzheimer's disease: progress and perspectives.

1 reference

12 December 2020

Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid beta-protein production in human neuronal NT2N cells

1 reference

12 December 2020

NGF Promotes Amyloid Precursor Protein Secretion via Muscarinic Receptor Activation

1 reference

12 December 2020

The selective muscarinic M1 agonist AF102B decreases levels of total Abeta in cerebrospinal fluid of patients with Alzheimer's disease

1 reference

12 December 2020

AF102B, a novel M1 agonist, enhanced spatial learning in C57BL/10 mice with a long duration of action

1 reference

12 December 2020

Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors

1 reference

12 December 2020

Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial

1 reference

12 December 2020

Muscarinic M1 receptor agonists increase the secretion of the amyloid precursor protein ectodomain

1 reference

12 December 2020

M1 muscarinic receptors block caspase activation by phosphoinositide 3-kinase- and MAPK/ERK-independent pathways

1 reference

12 December 2020

Increased levels of tau protein in SH-SY5Y cells after treatment with cholinesterase inhibitors and nicotinic agonists

1 reference

12 December 2020

Treatment with the selective muscarinic agonist talsaclidine decreases cerebrospinal fluid levels of total amyloid beta-peptide in patients with Alzheimer's disease.

1 reference

12 December 2020

Muscarinic control of amyloid precursor protein secretion in rat cerebral cortex and cerebellum

1 reference

12 December 2020

Loss of inositol 1,4,5-trisphosphate receptor sites and decreased PKC levels correlate with staging of Alzheimer's disease neurofibrillary pathology

1 reference

12 December 2020

Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice

1 reference

12 December 2020

Amyloid precursor protein secretion via muscarinic receptors: reduced desensitization using the M1-selective agonist AF102B

1 reference

12 December 2020

The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from chinese hamster ovary-m1 cells

1 reference

12 December 2020

Therapeutic strategies in Alzheimer's disease: M1 muscarinic agonists

1 reference

12 December 2020

Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion

1 reference

12 December 2020

Identifiers

DOI

10.1385/JMN:20:3:349

1 reference

Dimensions Publication ID

8 August 2017

1026532374

0 references

1 reference